Efficacy of low dose naltrexone for patients that suffer from comorbid depressive illness

The 15th Pacific Rim College of Psychiatrists Scientific Meeting
October 2012
https://onlinelibrary.wiley.com/doi/pdf/10.1111/appy.12002

Low-dose naltrexone for disease prevention and quality of life

Med Hypotheses
March 2009
https://pubmed.ncbi.nlm.nih.gov/19041189/

Low Dose Naltrexone in Dermatology

J Drugs Dermatol
March 2019
https://jddonline.com/articles/dermatology/S1545961619P0235X

Anxiolytics, adrenergic agents, and naltrexone

J Am Acad Child Adolesc Psychiatry
May 1999
https://pubmed.ncbi.nlm.nih.gov/10230186/

Microglial Phagocytosis of Neurons: Diminishing Neuronal Loss in Traumatic, Infectious, Inflammatory, and Autoimmune CNS Disorders

Front Psychiatr
03 October 2019
https://www.frontiersin.org/articles/10.3389/fpsyt.2019.00712/full

Changes in the consumption of antiepileptics and psychotropic medicines after starting low dose naltrexone: A nation-wide register-based controlled before-after study

Sci Rep
21 October 2019
https://pubmed.ncbi.nlm.nih.gov/31636347/

A novel glial cell inhibitor, low dose naltrexone, reduces pain and depression, and improves function in chronic pain: A CHOIR study

J Pain
01 April 2016
http://www.jpain.org/article/S1526-5900(16)00425-9/fulltext

Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants

J Affect Disor
15 January 2017
https://www.ncbi.nlm.nih.gov/pubmed/27736689

Could Low-Dose Naltrexone be an Effective Treatment for Hailey-Hailey Disease?

Integ Biomed Sci
19 July 2016
https://www.gratisoa.org/journals/index.php/MML/article/view/1293/957